This research confirms the existence of an intermediate category of melanocytic neoplasia.
The genetic evolution from nevus to melanoma has been a source of fascination, and debate, for years. It has long been recognized that BRAFV600E mutations occur quite frequently and early in acquired nevi. Additional mutational “hits” in nevi have not been reproducibly recovered, despite numerous analyses. To determine the sequence of genetic alterations in melanoma progression, these investigators analyzed 293 cancer-relevant genes in 150 areas of 37 primary melanomas and their adjacent precursor lesions, including lesions that were unequivocally benign, intermediate, and intraepidermal or invasive melanomas.
They found that benign lesions harbored only BRAFV600E mutations. Other lesions that contained BRAFV600E and NRAS mutations also harb…
Reviewing Author
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)